Cystic Fibrosis Market in Europe 2015-2019
Published: Feb 2015 Single User PDF: US$ 3000 Corporate User PDF: US$ 4500
Order this report by calling +1 888 391 5441 or Send an email to sales@reportsandreports.com with your contact details and questions if any.
Š ReportsnReports.com / Contact
Cystic Fibrosis Market in Europe 2015-2019 Cystic fibrosis, also known as mucoviscidosis, is a genetically inherited disease. The primary symptoms of cystic fibrosis include high salt content in the sweat, breathing difficulties, secretion of abnormally viscous mucus, respiratory complications, difficulties related to digestion, and growth anomalies. Cystic fibrosis is one of the most common genetic disorders observed in Caucasian children. Rare diseases are those that affect less than 5 patients per 10,000, as defined in the EU by Rare Disease UK. Cystic fibrosis is therefore classified under rare diseases. The incidence of cystic fibrosis varies between populations. It is significantly less common in Asian and African populations compared to Caucasians (people from Europe, North America, and Australasia), with a marked difference between each country in those regions. Precise data regarding the prevalence of cystic fibrosis in Europe is not available, but it is estimated to be 1 in 8,000-10,000 individuals. Analysts forecast the Cystic Fibrosis market in Europe to grow at a CAGR of 35.10 percent over the period 2014-2019.
Complete Report is Available @ http://www.reportsnreports.com/reports/344412-cystic-fibrosis-market-in-europe-2015-2019.html .
Š ReportsnReports.com / Contact
Cystic Fibrosis Market in Europe 2015-2019 Covered in this Report This report covers the present scenario and the growth prospects of the Cystic Fibrosis market in Europe for the period 2015-2019. To calculate the market size, the report considers the revenue generated from the sales of various generic and branded therapies used in the treatment of cystic fibrosis including: Small Molecules Biologics Cystic Fibrosis Market in Europe 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers data from Europe; it also covers the market landscape of the Cystic Fibrosis market in Europe and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Single User License of the Report is Available at USD 3000, Buy the Report @ http://www.reportsnreports.com/Purchase.aspx?name=344412 .
Š ReportsnReports.com / Contact
Cystic Fibrosis Market in Europe 2015-2019 Key Vendors Actavis F. Hoffmann-La Roche Gilead Sciences Novartis Vertex Pharmaceuticals
Complete Report is Available @ http://www.reportsnreports.com/reports/344412-cystic-fibrosis-market-in-europe-2015-2019.html .
Š ReportsnReports.com / Contact
Cystic Fibrosis Market in Europe 2015-2019 Other Prominent Vendors Abbott Anthera Pharmaceuticals Arcturus Therapeutics Boehringer Ingelheim Chiesi Farmaceutici Corbus Pharmaceuticals Genzyme Insmed Johnson & Johnson Merck Sharp & Dohme Neovii Biotech Novo Nordisk View all vendors Get discount on the Report @ http://www.reportsnreports.com/contacts/Discount.aspx?name=344412 .
Š ReportsnReports.com / Contact
Cystic Fibrosis Market in Europe 2015-2019 Market Driver Unmet Needs Market Challenge High Cost of Treatments Market Trend Rise in Public Awareness
Inquire Before buying the Report @ http://www.reportsnreports.com/contacts/InquiryBeforeBuy.aspx?name=344412 .
Š ReportsnReports.com / Contact
Cystic Fibrosis Market in Europe 2015-2019 Key Questions Answered in this Report What will the market size be in 2019 and what will the growth rate be? What are the key market trends? What is driving this market? What are the challenges to market growth? Who are the key vendors in this market space?
Browse All Reports on Pharmaceuticals market
Š ReportsnReports.com / Contact